Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$503K Buy
1,390
+84
+6% +$28.8K 0.06% 306
2026
Q1
$460K Buy
1,306
+10
+0.8% +$3.56K 0.06% 274
2025
Q4
$424K Buy
1,296
+96
+8% +$30.5K 0.06% 290
2025
Q3
$339K Sell
1,200
-106
-8% -$30.7K 0.05% 344
2025
Q2
$365K Buy
1,306
+133
+11% +$37.7K 0.05% 300
2025
Q1
$365K Sell
1,173
-438
-27% -$129K 0.06% 283
2024
Q4
$420K Buy
1,611
+133
+9% +$39.5K 0.07% 257
2024
Q3
$476K Sell
1,478
-60
-4% -$19.6K 0.08% 233
2024
Q2
$481K Sell
1,538
-37
-2% -$10.9K 0.09% 220
2024
Q1
$448K Buy
1,575
+75
+5% +$21.9K 0.08% 230
2023
Q4
$432K Sell
1,500
-7
-0.5% -$1.91K 0.08% 225
2023
Q3
$404K Buy
1,507
+17
+1% +$4.24K 0.08% 218
2023
Q2
$331K Buy
+1,490
New +$346K 0.06% 244

Other funds holding AMGN

Portside Wealth Group's AMGN Position: Q2 2026 in Review

Portside Wealth Group increased its Amgen (AMGN) stake by 6.4% in Q2 2026, buying an estimated $28.8K and bringing the position to 1,390 shares worth $503K. The position accounts for 0.06% of the portfolio, ranked #306.

Portside Wealth Group first reported a position in AMGN in Q2 2023 and has held it in 13 quarters since. 1,447 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Portside Wealth Group held 1,390 shares of Amgen worth $503K as of Q2 2026.
  • Portside Wealth Group bought 84 Amgen shares in Q2 2026, an estimated $28.8K.
  • Amgen made up 0.06% of Portside Wealth Group's portfolio in Q2 2026, its #306 holding.
  • Portside Wealth Group first reported a position in Amgen in Q2 2023 and has held it in 13 quarters since.
  • 1,447 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Portside Wealth Group's 13F filing for Q2 2026, filed 14 Jul 2026.